In an era when increasing demands are being made on the world’s healthcare services, generic and biosimilar medicines provide a major benefit to society by ensuring patient access to quality, safe and effective medicines while reducing the cost of pharmaceutical care.
The International Generic Pharmaceutical Alliance (IGPA) was founded in March 1997 as an international network of generic medicines associations. The name of the organization was changed in September 2015 to the International Generic and Biosimilar Medicines Association (IGBA) to reflect the evolving nature of the industry.
IGBA letter to FDA regarding their biologics naming proposalsThe International Generic and Biosimilar Medicines Association (IGBA), representing member associations from the U.S. (GPhA), Canada (CGPA), Japan (JGA), Jordan (JAPM), Europe (EGA), South Africa (NAPM), and Taiwan (TGPA), as well as associate member associations from Australia (GBMA), Brazil (ProGenericos)… Read More
IGBA Welcomes ICH Reform and Openness For New MembersJOHANNESBURG, SOUTH AFRICA (November 3, 2015).- The International Generic and Biosimilar Medicines Association (IGBA) welcomed the International Conference on Harmonisation (ICH) reform and the opening of the process to new members, including international industry organisations. The IGBA fully recognises the… Read More
IGPA becomes IGBA and chairmanship shifts to South AfricaTORONTO, CANADA (October 13, 2015).- Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA) and Chair of the IGBA, announced at the IGBA Conference in Toronto that the International Generic and Biosimilar Medicines Association (IGBA) will register as an… Read More
Global Pharmaceutical Associations Welcome MEDICRIME Convention, Landmark Tool to Curb Global Medicines Counterfeiting1 October 2015 – A unique international tool criminalizing the trade of counterfeit medicines, the Medicrime Convention, will enter into force on 1st January 2016, after 5 countries out of its 24 signatories completed the ratification process. The Medicrime Convention, launched… Read More
Statement by the International Generic Pharmaceutical Alliance (IGPA), Regarding the Trans-Pacific PartnershipJune 30, 2015 – The International Generic Pharmaceutical Alliance (IGPA) urges negotiators for the Trans-Pacific Partnership (TPP) not to abandon the needs of millions of the world’s citizens for access to affordable medicines. Read More